Abstract
Chemotherapy remains the most widely used cancer treatment modality. Nanotechnology provides exciting opportunities to improve these drugs, transforming decades-old generic treatments into precise new medicines. We illustrate the potential of recent advances in nanotechnology-enhanced therapy focusing on diffuse large B-cell lymphoma (DLBCL); the most common hematologic malignancy.
Author supplied keywords
Cite
CITATION STYLE
APA
Arumov, A., Trabolsi, A., & Schatz, J. H. (2021, October 1). Potency Meets Precision in Nano-optimized Chemotherapeutics. Trends in Biotechnology. Elsevier Ltd. https://doi.org/10.1016/j.tibtech.2021.03.004
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free